ZYXI Investors Called to Lead Charge in Zynex, Inc. Securities Fraud Case with the Schall Law Firm

Los Angeles, CA – Investors who have incurred losses from Zynex, Inc. are presented with the opportunity to potentially lead a collective lawsuit regarding alleged securities fraud. The Schall Law Firm, a nationally recognized shareholder rights litigation firm, is actively seeking participants who have faced financial damage from investments in the stock between February 26, 2021, and April 5, 2022. During this period, Zynex, Inc., a company known for manufacturing non-invasive medical devices for pain management and rehabilitation, is accused of providing misleading information to shareholders, directly impacting stock values. This includes optimistic revenue guidance … Read more

Zynex, Inc. (ZYXI) Shareholders: Explore Your Options in Ongoing Securities Fraud Investigation with Howard G. Smith Law Offices

Broomfield, Colorado – Shareholders who have incurred financial losses from their investments in Zynex, Inc. (ZYXI), a medical technology company, are being alerted to a developing securities fraud investigation. The Law Offices of Howard G. Smith is spearheading the probe amidst concerns surrounding alleged misleading statements and potentially unlawful business practices that might have skewed the company’s stock valuation. Zynex, known for manufacturing non-invasive medical devices for pain management, rehabilitation, and electrotherapy, recently came under scrutiny. The investigation by the Law Offices of Howard G. Smith focuses primarily on whether the company or its executives … Read more